Lipoxygenase Inhibitors for Cancer Prevention: Promises and Risks
Journal:
Current Pharmaceutical Design
Volume:
16
Page:
725-733
Author(s):
Cecilia Menna, Fabiola Olivieri, Alfonso Catalano and Antonio Procopio
IP6 in Cancer Therapy: Past, Present and Future
Journal:
Current Cancer Therapy Reviews
Volume:
6
Page:
1-12
Author(s):
Agata Matejuk and Abulkalam Shamsuddin
Endocrine Therapy for Advanced Breast Cancer: Beyond Tamoxifen and Aromatase Inhibitors
Journal:
Current Cancer Therapy Reviews
Volume:
6
Page:
51-61
Author(s):
Angel Guerrero-Zotano and Franco Muggia
Diabetes Mellitus: Channeling Care through Cellular Discovery
Journal:
Current Neurovascular Research
Volume:
7
Page:
59-74
Author(s):
Kenneth Maiese, Yan Chen Shang, Zhao Zhong Chong and Jinling Hou
Hormone-Biological Therapy in Breast Cancer: Preclinical Evidence,Clinical Studies and Future Directions
Journal:
Current Cancer Drug Targets
Volume:
10
Page:
3-18
Author(s):
G. Schiavon and G. Tonini
Manipulation of Glycolysis in Malignant Tumors: Fantasy or Therapy?
Journal:
Current Medicinal Chemistry
Volume:
17
Page:
96-108
Author(s):
U. G.A. Sattler, F. Hirschhaeuser and W. F. Mueller-Klieser
Pharmacotherapy for Obesity
Journal:
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)
Volume:
4
Page:
47-58
Author(s):
Alex H.C. Wong, Stefani S.N. Barg and Alexander K.C. Leung
Breast Cancer Chemoprevention: Current Perspectives
Journal:
Current Enzyme Inhibition
Volume:
5
Page:
198-208
Author(s):
Takeru Oyama, Yumiko Yasui and Takuji Tanaka
Indoleamine 2,3-Dioxygenase, an Emerging Target for Anti-Cancer Therapy
Journal:
Current Cancer Drug Targets
Volume:
9
Page:
938-952
Author(s):
X. Liu, R. C. Newton, S. M. Friedman and P. A. Scherle
Personalizing HER2-Targeted Therapy in Metastatic Breast Cancer Beyond HER2 Status: What We Have Learned from Clinical Specimens
Journal:
Current Pharmacogenomics and Personalized Medicine
Volume:
7
Page:
263-274
Author(s):
R. Nahta, S. Shabaya, T. Ozbay and D. L. Rowe